![India must reject Johnson & Johnson's attempt to extend monopoly on lifesaving TB drug bedaquiline | Médecins Sans Frontières Access Campaign India must reject Johnson & Johnson's attempt to extend monopoly on lifesaving TB drug bedaquiline | Médecins Sans Frontières Access Campaign](https://msfaccess.org/sites/default/files/styles/msf_wide/public/2023-01/TB_Belarus_Bedaquiline_2022_AlexandraSodokova_MSB137912_3800px.jpg.webp?itok=xHw3YYj5)
India must reject Johnson & Johnson's attempt to extend monopoly on lifesaving TB drug bedaquiline | Médecins Sans Frontières Access Campaign
![As WHO issues new TB treatment guidelines, MSF calls for urgent scale-up of all-oral treatment | Médecins Sans Frontières Access Campaign As WHO issues new TB treatment guidelines, MSF calls for urgent scale-up of all-oral treatment | Médecins Sans Frontières Access Campaign](https://www.msfaccess.org/sites/default/files/styles/msf_wide/public/2018-12/TB_Ukraine_OksanaParafeniuk_2018_MSF248559_3800px.jpg.webp?itok=pSuOKclu)
As WHO issues new TB treatment guidelines, MSF calls for urgent scale-up of all-oral treatment | Médecins Sans Frontières Access Campaign
![International trial finds better treatment for people with drug-resistant tuberculosis | UCL Faculty of Medical Sciences - UCL – University College London International trial finds better treatment for people with drug-resistant tuberculosis | UCL Faculty of Medical Sciences - UCL – University College London](https://www.ucl.ac.uk/medical-sciences/sites/medical_sciences/files/styles/large_image/public/2018_msf176551_medium.jpg?itok=urNqD7zD)
International trial finds better treatment for people with drug-resistant tuberculosis | UCL Faculty of Medical Sciences - UCL – University College London
![F.D.A. Approves New Treatment for Deadliest Strain of Tuberculosis | Smart News| Smithsonian Magazine F.D.A. Approves New Treatment for Deadliest Strain of Tuberculosis | Smart News| Smithsonian Magazine](https://th-thumbnailer.cdn-si-edu.com/N9e0RZYQZlDgrie0EsXEqIGsb7w=/fit-in/1600x0/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer/05/be/05be66b8-db03-4ad2-9a9c-1705573183f2/ht_190814_pretomanid_tablet_800x450.jpg)
F.D.A. Approves New Treatment for Deadliest Strain of Tuberculosis | Smart News| Smithsonian Magazine
![Sirturo (bedaquiline) for Treatment of Pulmonary Multi-Drug Resistant Tuberculosis (TB) - Clinical Trials Arena Sirturo (bedaquiline) for Treatment of Pulmonary Multi-Drug Resistant Tuberculosis (TB) - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1l-image-22.jpg)